---
schema_version: "secwatch.filing_event.v1"
accession: "0000075252-23-000004"
form_type: "8-K"
ticker: "ACH"
cik: "0000075252"
company_name: "ACCENDRA HEALTH INC/VA/"
filed_at: "2023-02-28T23:59:59+00:00"
generated_at: "2026-06-18T22:57:25.511737+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Owens & Minor reports Q4 GAAP operating loss of $53.5M; launches cost-cutting program targeting $200M by 2025

## Summary
- Q4 revenue $2,551M, up 3.4% YoY; full-year revenue $9,955M, up 1.7%.
- Q4 GAAP net loss $58.0M ($0.77 loss per share); adjusted net income $21.7M ($0.28 per share).
- Patient Direct Q4 revenue up 135% (10.3% adjusted for Apria); full-year operating cash flow $325M.
- Operating Model Realignment Program targets $30M adjusted operating income in 2023, $200M by 2025, and $250-400M working capital benefit.
- Perry Bernocchi promoted to CEO of Patient Direct segment; Dan Starck named EVP Business Excellence, both effective March 1, 2023.

## SEC filing metadata
- accession: 0000075252-23-000004
- form_type: 8-K
- ticker: ACH
- cik: 0000075252
- company_name: ACCENDRA HEALTH INC/VA/
- filed_at: 2023-02-28T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/75252/000007525223000004/0000075252-23-000004-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/75252/000007525223000004/omi-20230228.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000075252-23-000004
- JSON: https://secwatch.observer/filing/0000075252-23-000004.json
- Plain text: https://secwatch.observer/filing/0000075252-23-000004.txt

## Key facts
- Earnings Releases
  ACCENDRA HEALTH INC/VA/ reported the year ended December 31, 2022 results: revenue $9,955, net income $22.4, EPS $0.29.
  - Period: the year ended December 31, 2022
  - Revenue: $9,955
  - Net income: $22.4
  - EPS: $0.29
  - Result: reported results
  source text: Financial Summary (1) FYE FYE ($ in millions, except per share data) 4Q22 4Q21 2022 2021 Revenue $2,551 $2,467 $9,955 $9,785 Operating (loss) income, GAAP $(53.5) $62.0 $142.9 $368.5 Adj. Operating Income, Non-GAAP $67.2 $84.9 $369.1 $442.4 Net (loss) income, GAAP $(58.0) $42.0 $22.4 $221.6 Adj. Net Income, Non-GAAP $21.7 $61.2 $184.2 $309.3 Adj. EBITDA, Non-GAAP $116.7 $97.4 $517.8 $492.3 Net (loss) income per common share, GAAP $(0.77) $0.55 $0.29 $2.94 Adj. Net Income per share, Non-GAAP (2) $0.28 $0.81 $2.42 $4.10
  evidence_url: https://www.sec.gov/Archives/edgar/data/75252/000007525223000004/0000075252-23-000004-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.